MTOR and autosomal dominant polycystic kidney disease: All previously conducted clinical trials, with the exception of one recently published randomized controlled pilot study [21], could not demonstrate any clinically relevant effect of mTOR inhibition on cyst growth or kidney function (Interventions for retarding the progression of autosomal dominant polycystic kidney disease (ADPKD): A systematic review and meta-analysis.